-
Forward Look
Orphan Drugs Still Find a HomeThirty years on, landmark federal legislation continues to benefit patients with rare cancers.
by Emily Gertz
-
Survivor Profile
Patients’ Rights PowerhouseMyra Christopher wages a personal battle with a rare cancer while continuing to passionately advocate for patients.
by Charlotte Huff
-
Survivor Profile
Let’s Talk: Lee MillerDrawing on her own struggle with the emotional pain of a cancer diagnosis and treatment, Lee Miller empowers other patients to effectively communicate with their doctors.
by Jenny Song
-
Forward Look
Confronting Lung Cancer StigmaAn ad campaign shines a light on lung cancer blame.
by Yvonne Lee
-
First Person
Keeping Sight of HopeA survivor keeps an eye on what's ahead after a rare cancer diagnosis.
by Sue Russell
-
Yesterday & Today
The Sex Machine vs. Prostate CancerEven cancer couldn't slow down James Brown.
by Jocelyn Selim
-
Survivor Profile
Touched by an AngelJonny Imerman is the heart and hub of a network of cancer survivors.
by Pamela Ferdinand
-
Yesterday & Today
A Leading LadyBetty Ford's candor about her breast cancer diagnosis helped bring a private issue out of the shadows.
by Corinna Wu
-
Teaming Up for Better TreatmentAcross the country, survivors' opinions and actions are influencing cancer care.
by Stephen Ornes
-
Stranger in a Strange LandCancer puts everyone in foreign territory, but those diagnosed with a rare form of the disease may feel the most lost without clear guidance toward the best care or support from other survivors. Four steps can help ease the way.
by Rabiya S. Tuma
U.S. breast cancer deaths declined for women ages 20 to 49, which researchers credit to wider screening and better treatment.
by Kevin McLaughlin
Missed Activities Due to Cancer-related Fatigue and DepressionWomen were more likely than men to have fatigue or depression linked to cancer, and both effects were linked to people withdrawing from physical activities.
by Eric Fitzsimmons
Immunotherapy Improves Results in Head and Neck CancerCombining an immune checkpoint inhibitor with standard care extended event-free survival by nearly two years.
by Thomas Celona
Federal Support for Cancer Research Takes the Stage at AACR Annual MeetingScientists and former administrators gather for session focused on advocating for cancer research in uncertain times.
by Kevin McLaughlin
-
Inaugural AACR IO Conference Kicks Off With Celebration of Immune CheckpointsImmune checkpoint icons James Allison and Arlene Sharpe shared their journeys and a look ahead on the opening night of the inaugural AACR IO conference.
-
A New Resource Provides a Sanctuary for Black TNBC PatientsThe Black TNBC Sanctuary was created to help Black women with triple-negative breast cancer get answers about their diagnosis and care.
Dr. Humberto M. Guiot: Targeting Pancreatic Cancer in a Community-Based Clinical Trial
